Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock

This publication has 14 references indexed in Scilit:

• Letʼs agree on terminology
  Critical Care Medicine, 1991
• Extracellular phospholipase A2 secretion is a common effector pathway of interleukin-1 and tumour necrosis factor action
  Immunology Letters, 1991
• A specific receptor antagonist for interleukin 1 prevents Escherichia coli ‐induced shock in rabbits
  The FASEB Journal, 1991
• Compartmental heterogeneity of soluble phospholipases A
  Inflammation, 1990
• Release of phospholipase A₂ activity from rat vascular smooth muscle cells mediated by cAMP
  European Journal of Biochemistry, 1989
• Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
  Journal of Clinical Investigation, 1988
• Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.
  Journal of Clinical Investigation, 1988
• Pathogenesis of hypotension in septic shock
  Critical Care Medicine, 1988
• Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia
  Nature, 1987
• Involvement of circulating phospholipase A₂ in the pathogenesis of the hemodynamic changes in endotoxin shock
  Canadian Journal of Physiology and Pharmacology, 1983